"At Smilow Cancer Hospital Care Centers, we offer state-of-the-art cancer services at several convenient locations throughout the region."

During the past decade, Smilow Cancer Hospital-Orange Care Center conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 21 clinical trials were completed, i.e. on average, 36.2% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 19 clinical trials were completed. i.e. 86.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Smilow Cancer Hospital-Orange Care Center" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Smilow Cancer Hospital-Orange Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital-Orange Care Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "HER2/Neu Negative" (4 trials), "Invasive Breast Carcinoma" (4 trials) and "Stage III Breast Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Smilow Cancer Hospital-Orange Care Center" in a lesser frequency.

Most popular intervention types in "Smilow Cancer Hospital-Orange Care Center" are "Drug" (55 trials), "Other" (48 trials), "Biological" (33 trials), "Procedure" (15 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (19 trials), "Computed Tomography" (13 trials), "Questionnaire Administration" (11 trials) and "Biospecimen Collection" (10 trials). Other intervention names were less common.

The vast majority of trials in "Smilow Cancer Hospital-Orange Care Center" are 57 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Smilow Cancer Hospital-Orange Care Center". undefined are not yet recruiting, 18 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Smilow Cancer Hospital-Orange Care Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Smilow Cancer Hospital-Orange Care Center, 4 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".